A Study of AK129 in Patients With Advanced Malignant Tumors

Clinical trial NCT05645276 · RECRUITING

Trial details

NCT number: NCT05645276
Sponsor: Akeso
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Tumors(Stage IA-IB)

Start date: 2023-03-02
Primary completion: 2026-02-01
Enrollment: 182

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.